Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

Jens Overgaard, Hanne Sand Hansen, Lena Specht, Marie Overgaard, Cai Grau, Elo Andersen, Jens Knud Daugaard Bentzen, Lars Bastholt, Olfred Hansen, Jørgen Johansen, Lisbeth Andersen, Jan F Evensen

605 Citations (Scopus)

Abstract

Although head and neck cancer can be cured by radiotherapy, the optimum treatment time for locoregional control is unclear. We aimed to find out whether shortening of treatment time by use of six instead of five radiotherapy fractions per week improves the tumour response in squamous-cell carcinoma.
Original languageEnglish
JournalLancet
Volume362
Issue number9388
Pages (from-to)933-40
Number of pages8
ISSN0140-6736
Publication statusPublished - 20 Sept 2003

Fingerprint

Dive into the research topics of 'Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial'. Together they form a unique fingerprint.

Cite this